ЭНДОТОКСИНЕМИЯ И АТЕРОСКЛЕРОЗ
Аннотация
Изучается гипотеза вовлечения бактериальных липолоисахаридов наразвитие и прогрессирование атеросклероза. Специальный акцент седлан на частоте эндотоксинемии, времени продолжения действия биоактивного эндотоксина в тканях, связи междлу атеросклерозом и инфекциями, вызванными грам-отрицательными бактериями, плазменными и клеточными мишенями, а также проатерогенным действием эндотоксина. Высказано и детально обсуждено предположение о возможной роли комплексов ЛПС-липопротеин. Представлены литературные данные по эффектам эндотоксина на метаболизм липопротеинов и образование пенистых клеток.
Об авторах
Я. Ш. Шварц
НИИТ СО РАМН, НИИКИ СО РАМН, Новосибирск
Россия
Россия
М. И. Душкин
НИИТ СО РАМН, НИИКИ СО РАМН, Новосибирск
Россия
Россия
Список литературы
1. Душкин М.И., Шварц Я.Ш., Рагино Ю.И., Сафина А.Ф. Повышенный синтез липидов в воспалительных макрофагах: возможная роль цитокинов в образовании пенистых клеток. // Материалы 1 Всероссийской конференции по проблемам атеросклероза, посвященной 100-летиюА.Л.Мясникова, Москва, 1999, с. 54
2. Климов А.Н., Никульчева Н.Г. Обмен липидов и липопротеидов и его нарушения (Руководство для врачей), 3-еизд. - СПб.: Питер ком, 1999. - 512 с.
3. Титов В.Н. Общность атеросклероза и воспаления: специфичность атеросклероза как воспалительного процесса. // Российск. кардиол. журн. - 1999. - №5 - С.48-56.
4. Шенкман Б.З. Молекулярные и клеточные механизмы патогенного действия бактериальных эндотоксинов. // Усп. совр. биол. - 1988. - Т.105. - №3. - С.423-428.
5. Усынин И.Ф., Цырендоржиев Д.Д., Харьковский А.В., Поляков Л.М., Панин Л.Е. Влияние липопротеинов плазмы крови и аполипопротеина A-I налипополисахарид-индуцированную продукцию реактивных метаболитов кислорода клетками Купфера у крыс. // Биохимия - 1996. - Т.61, №2. - С.193-196.
6. Aggarwal B.B., Natarajan K. Tumor necrosis factors: Developments during the last decade. // Eur. Cytokine Netw. - 1996. - Vol.7(2) - P.93-124.
7. Alexander J.W. The role of nutrition in preventing bacterial translocation. // In: Abstracts of IBC’s 5th annual innovative strategies for the prevention and treatment of endotoxinemia and sepsis. June 19-21 1995, Philadelphia.
8. Asada Y, Marutsuka K, Hatakeyama K, Sato Y, Hara S, Kisanuki A, Sumiyoshi A The role of tissue factor in the pathogenesis of thrombosis and atherosclerosis. // J. Atheroscler. Thromb. - 1998. - Vol.4(3). - P.135-139.
9. Aviram M. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. // Isr. J. Med. Sci. - 1995. - Vol.31(4). - P.241-249.
10. Bahrami S., Schlag G., Yao Y-M., Redl H. Significance of translocation/endotoxin in the development of systemic sepsis following trauma and/or haemorrhage. // In: Progress in clinical and biological research, Vol.392: Bacterial endotoxins: Lipopolysaccharides from genes to therapy (Eds. J.Levin, C.R.Alving, R.S.Munford, H.Redl), Wiley-Liss Inc. - 1995. - P.197-208.
11. Beck J., Garcia R., Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. // J. Periodontol. - 1996. - Vol.67(10 Suppl). - P.1123-1137.
12. Berger D., Bolke E., Seidelmann M., Vasilescu C., Beger H.G. Endotoxin-induced cytokine release from whole blood - similarities between monocyte dysfunction in septic disease and during postoperative acute phase response. // J.Endotoxin Res. - 1997. - Vol.4, №1. - P.17-24.
13. Bertok L. Role of bile acids in endotoxin induced patrhological processes. // J.Endotoxin Res. - 1996. - Vol.3. (Suppl.1). - P.16.
14. Brade H., Brabetz W., Brade L., Holst O., Lobau S., Mucakova M., Mamat U., Rozalski A., Zych K., and Kosma P. Chlamydial lipopolysaccharide. // J. Endotoxin Res. - 1997. - Vol.4(1). - P.67-84.
15. Castells A., Hurtado I., Fiol C. Oxidized LDL and apoptosis. // Atherosclerosis - 1997. - Vol.134,(1,2). - P.228.
16. Cavaillon J. M., Fitting C., Haeffner-Cavaillon N., Kirsch S. J., Warren H. S. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. // Infect. Immun. - 1990. - Vol.58. - P.2375–2382.
17. ed with chronic inflammatory disease to stimulate E-selectin expression and neutrophil adhesion. // In: Progress in clinical and biological research, vol.392: Bacterial endotoxins: Lipopolysaccharides from genes to therapy (Eds. J.Levin, C.R.Alving, R.S.Munford, H.Redl), Wiley-Liss Inc. - 1995. - P. 69-78.
18. Duncan R.L.Jr., Hoffman J., Tesh V.L., Morrison D.C. Immunologic activity of liopolysaccharides released from macrophages after the uptake of intact E.coli in vitro. // J. Immunol. - 1986 - Vol.136. - P.2924-2929.
19. Ebentreich U., Steinmetz W.-G., Thiede A., Holzheimer R.G. IL- 10 kinetiks after antibiotic induced endotoxin release in colorectal operations. // J.Endotoxin Res. - 1996. - Vol.3, (Suppl.1). - P.20.
20. Ebersole J.L., Cappelli D., Mott G., Kesavalu L., Holt S.C., Singer R.E. Systemic manifestations of periodontitis in the non-human primate. // J. Periodontal Res. - 1999. - Vol.34(7). - P.358-362.
21. Engelmann B, Zieseniss S, Brand K, Page S, Lentschat A, Ulmer A.J., Gerlach E. Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. // Arterioscler. Thromb. Vasc. Biol. - 1999. - Vol.19(1). - P.47-53.
22. Feingold K.R., Soued M., Adi S., Staprans I., Neese R., Shigenaga J., Doerrler W., Moser A., Dinarello C.A., Grunfeld C. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. // Atherosclerosis and Thrombosis. - 1991. - Vol.11. - P.495-500.
23. Flegel W.A., Wolpl A., Mannel D.N., Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lioproteins. // Infect. and Immun. - 1989. - Vol.57(7). - P.2237-2245.
24. Flegel W.A., Baumstark M.W., Weinstock C., Berg A., Northoff H. Prevention of endotoxin-induced monokine release by human lowand high-density lipoproteins and by apolipoprotein A-I. // Infect. Immun. - 1993. - Vol.61. - P.5140-5146.
25. Fong I. W., Chiu B., Viira E., Jang D., Mahony J. B. De Novo Induction of Atherosclerosis by Chlamydia pneumoniae in a Rabbit Model. // Infect. Immun. - 1999 - Vol.67. - P.6048-6055.
26. Freudenberg M.A., Bog-Hansen T.C., Back U., Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. // Infect. Immun. - 1980. - Vol.28. - P.373-380.
27. Freudenberg M.A., Galanos C. The metabolic fate of endotoxins. In: Bacterial Endotoxins: Pathophysiological Effects, Clinical Significance, and Pharmacological Control (Eds. Levin J., Buller H.L., ten Cate J.W., van Deventer S.J.H., Stark A.) Alan R. Liss, NY. - 1988. - P.63-75.
28. Freudenberg M.A., Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. // Infect. Immun. - 1988. - Vol.56. - P.1352-1357.
29. Freudenberg M.A., Galanos C. Metabolism of LPS in vivo. // In: Bacterial endotoxic lipopolysaccharides, Vol.2 Immunopharmacology and Pathophysiology (Eds. J.L.Ryan and D.C.Morrison), CRC Press. - 1992. - P.275-294.
30. Grunfeld C., Gulli R., Moser A.H., Gavin L.A., Feingold K.R. Effect of tumor necrosis factor administration in vivo on lipoproteinlipase activity in various tissues of the rat. // J.Lipid Res. - 1989. - Vol.30. - P.579-585.
31. Gupta M., Parker J.L., Adams H.R., Myers P.R. Chronic endotoxemia supresses atherogenesis in rabbit aorta [abstract]. // Circulation - 1993. - Vol.88(I). - P.522.
32. Hansson G.K. Cell-mediated immunity in atherosclerosis. // Current opinion in lipidology - 1997. - Vol.8. - P.301-311.
33. Hardardottir I. Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. // Curr. Opin. Lipidol. - 1994. - Vol.5. - P.207-215.
34. Harris H.W., Grunfeld C., Feingold K.R., Rapp J.H. Human very low density lipopoteins and chylomicrons can protect against endotoxin-induced death in mice. // J. Clin. Invest. - 1990. - Vol.86. - P.696-702.
35. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J. et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. // Immunity - 1996. - Vol.4. - P.407-414.
36. Hurley J.C. Antibiotic-induced release of endotoxin: a reappraisal. / / Clin.Infect.Dis. - 1992. - Vol.15. - P.840-854.
37. Ilyinskaya O.P., Loktionova S.A., Arefieva A.M., Yarovaya E.B. Polyploidization of aortic endothelium in human ontogenesis: Relation to atherosclerosis. // Atherosclerosis - 1997. - Vol.134 (1,2). - P.242
38. Iwagaki H., Hizuta A., Yoneyama M., Tanaka N. Preoperative lactosucrose administration and its effect on postoperative serum endotoxin level. // J.Endotoxin Res. - 1996. - Vol.3, (Suppl.1.) - P.24.
39. Jackson J.J., Kropp H. Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeroginosa: in vivo relevance. In: Progress in clinical and biological research, vol.392: Bacterial endotoxins: Lipopolysaccharides from genes to therapy (Eds. J.Levin, C.R.Alving, R.S.Munford, H.Redl), Wiley-Liss publishing. - 1995. - P.235-251.
40. Jackson J.J., Kropp H. Antibiotic-induced endotoxin release: important parameters dictating responses. // In: Endotoxin in health and disease (Eds. H.Brade, S.M.Opal, S.N.Vogel, D.C.Morrison), Marce Dekker Inc. Publishing. - 1999. - P.968
41. Jackson I., Campbell L., Kuo C., Rodriguez D., Lee A., and Grayston J. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. // J. Infect. Dis. - 1997. - Vol.176. - P.292-295.
42. Kaiser S., Heinig B., Toborek M. Apoptosis of vascular endothelial cells in response to TNF and lipid treatments. // Atherosclerosis - 1997. - Vol.134 (1,2). - P.243.
43. Kalayoglu M., Byrne G. Induction of macrophage foam cell formation by Chlamydia pneumoniae. // J. Infect. Dis. - 1998. - Vol.177. - P.725-729.
44. Kalayoglu M. V., Byrne G. I. A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial LPS. // Infection and Immunity - 1998. - Vol.66, No. 11. - P. 5067-5072.
45. Kaplanski G., Farigoule M., Boulay V., Dinarello C.A., Bongrand P., Kaplanski S., Farnarier C. Thrombin induces endothelial type II activation in vitro. IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. // J.Immunol. - 1997. - Vol.158. - P.5435-5441.
46. Kerttula Y., Vaara M., Pyhala L., Sariola H., Kostiainen E., Huttunen J.K. Effect of bacterial lipopolysaccharide on serum lipids and on the development of aortic atherosclerosis in rabbits. // Atherosclerosis - 1986. - Vol.59. - P.307-312.
47. Kitano H., Fukui H., Morimura M, Kikuchi E., Matsumoto M., Kikukawa M., Nagamoto I., Hoppou K., Nakatani Y., Takaya A. Metabolic fate of endotoxin and blood tumor necrosis factor levels in rats with acute and chronic alcohol loading. // J.Endotoxin Res. - 1996. - Vol.3 (Suppl.1). - P.20.
48. Kitchens R. L., Wolfbauer G., Albers J. J., Munford R. S. Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface. // J. Biol. Chem. - 1999. - Vol.274 - P.34116-34122.
49. Korner I., Blatz R., Wittig I., Pfeiffer D., Ruhlmann C. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions. // Vasa - 1999. - Vol.28(4). - P.259-263.
50. Kuo, C., A. Gown, E. Benditt, and J. Grayston. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. // Arterioscler. Thromb. - 1993. - Vol.13 - P.1501-1504.
51. Kuo, C., J. Grayston, L. Campbell, Y. Goo, R. Wissler, and E. Benditt. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). // Proc. Natl. Acad. Sci. USA - 1995. - Vol.92. -P.6911-6914.
52. Lehr H.A., Sagban T.A., Zahringer U., Hungerer K.P., Blumrich M., Bhakdi S. Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. // Atherosclerosis - 2000. - Vol.151, № 1. - P.193
53. Levine D.M., Parker T.S., Donnely T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoproteins. // Proc. Natl. Acad. Sci. - 1993. - Vol.90. - P.12040-12044.
54. Li W, Tada T, Miwa T, Okada N, Ito J, Okada H, Tateyama H, Eimoto T mRNA expression of complement components and regulators in rat arterial smooth muscle cells. // Microbiol. Immunol. - 1999. - Vol.43(6). - P.585-593.
55. Liao W., Floren C.H. Endotoxins inhibit endocytotic catabolism of low density lipoproteins in Hep 2G cells. // J.Biol.Chem. - 1992. - Vol.16 - P.224-231.
56. Liao W., Floren C.H. Endotoxin, cytokines and hyperlipidemia. // Scand. J. Gastroenterol. - 1993. - Vol.28. - P.97-103.
57. Liao W., Floren C.H. Enhancement by lipoprotein-free plasma of the inhibitory effect of endotoxin on endocytotic catabolism of low density lipoproteins in Hep 2G cells. // Eur. J. Biochem. - 1994. - Vol.220. - P.349-357.
58. Liao W. Endotoxin: possible role in initiation and development of atherosclerosis. //J.Lab.Clin.Med. - 1996. - Vol.128(5). - P.452-460.
59. Libby P., Hansson G.K. Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.//Lab.Investigation. - 1991. - Vol.64. - P.5-15.
60. Liehr H. RES function in experimental and human liver disease. // Reticuloendothel. Syst.: Compr. Treatise. - 1985. - Vol.7B. - P.223-246.
61. Linnanmaki E., Leinonen M., Mattila K., Nieminen M., Valtonen V., and Saikku P. Chlamydia pneumoniaespecific circulating immune complexes in patients with chronic coronary heart disease. // Circulation - 1993. - Vol.87. - P.1130-1134.
62. Lugtenberg B., van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other Gram-negative bacteria. // Biochim. Biophys. Acta - 1983. - Vol.737. - P.51-115.
63. Machledo G.W. Bacterial translocation following trauma and hemorrhage. // In: Abstracts of IBC’s 5th annual innovative strategies for the prevention and treatment of endotoxinemia and sepsis. June 19-21 1995, Philadelphia.
64. Mathison J.C., Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intraveniously injected lipopolysaccharide in rabbits. // J.Immunol. - 1979. - Vol.123. - P.2133-2143.
65. Moazed T., Kuo C., Grayston J., Campbell L.. Murine models of Chlamydia pneumoniae infection and atherosclerosis. // J. Infect. Dis. - 1997. - Vol.175. - P.883-890.
66. Morrison D.C., Danner R.L., Dinarello C.A., Munford R.S., Natanson C., Pollak M., Spitzer J.J., Ulevitch R.J., Vogel S.N., McSweegan E. Bacterial endotoxins of Gram-negative infections: current status and future direction. // J.Endotoxin Research - 1994. Vol.1 - P.71-83.
67. Morrison D.C. Perspective - pathophysiologic and therapeutiv significance of antibiotic-induced endotoxin release. // J.Endotoxin Res. - 1996. - Vol.3, (Suppl.1.) - P.7.
68. Muhlestein J., Anderson J., Hammond E., Zhao L., Trehan S., Schwobe E., Carlquist J.. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. // Circulation - 1998. - Vol.97. - P.633-636.
69. Munster A.M. Control of endotoxinemia in burn patients. In: Abstracts of IBC’s 5th annual innovative strategies for the prevention and treatment of endotoxinemia and sepsis. June 19-21 1995, Philadelphia.
70. Murota S-i., Nishida M., Morita I. Suppression of gap junctional intercellular communication in HUVEC by neutrophil adhesion. // In: Atherosclerosis XI (Eds. B.Jacotot, D.Mathe, J.-C.Fruchard), Elsevier Science Pte Ltd. - 1998. - P. 969-972.
71. Netea M.G., Selzman C.H., Kullberg B.J., Galama J.M., Weinberg A., Stalenhoef A.F., Van der Meer J.W., Dinarello C.A. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. // Eur. J Immunol. - 2000. - Vol.30(2). - P.541-549.
72. Noguchi K., Chen X.M., Oriishi T., Sasatomi K., Mimura Y., Oishi M., Koga H., Harada M., Shakado S., Sakisaka S., Sata M.., Tanikawa K. Absorptive pathway of endotoxin through colonic epithelium of chronic ethanol-fed rat. // J.Endotoxin Res. - 1996. - Vol.3, - Suppl.1. - P.17.
73. Nolan J.P. The contribution of gut-derived endotoxins to liver injury. // Yale J. of Biol. and Med. - 1979. - Vol.52, - P.127-133.
74. Nolan J.P., Camara D.S. Endotoxin and liver disease. // In: Sinusoidal Liver Cells (Eds. Knook D.L., Wisse E.), Elsvier Biomed. Press - 1982. - P. 377-386.
75. Norata G.D., Roma P., Catapano A.L. Oxidized LDL induce apoptosis in human endothelial cells. // Atherosclerosis - 1997. - Vol.134 (1,2). - P.245.
76. Pugin J., Ulevitch R.J., Tobias P.S. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14. // In: Progress in clinical and biological research, vol.392: Bacterial endotoxins: Lipopolysaccharides from genes to therapy (Eds. J.Levin, C.R.Alving, R.S.Munford, H.Redl), Wiley-Liss Inc. - 1995. - P.369-373.
77. Pugin J., Ulevitch R.J., Tobias P.S. Tumor necrosis factor alpha and interleukin 1 beta mediate human endothelial activation in blood at low endotoxin concentrations. // J. Inflammation - 1995. - Vol.45. - P.49-55.
78. Ramamurthy F.L., Pittilio R.M., Abbas B., Bandara A., Wells C. Endothelial cells and dye-sensitised exposure to singlet oxygen. // Atherosclerosis - 1997. - Vol.134(1,2). - P.245.
79. Reidy M.A., Bowyer D.E. Distortion of endothelial repair. The effect of hypercholesterolemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscopy. // Atherosclerosis - 1978. - Vol.29. - P.459-466.
80. Rensen P.C.N., van Oosten M., van de Bilt E., van Eck M., Kuiper J., van Berkel Th.J.C. Human apolipoprotein E prevents against the deleterious effects of bacterial liposaccharides in rats in vivo. // Atherosclerosis - 1997 - Vol.134(1,2). - P.379.
81. Rensen P.C.N., van Oosten M., van Eck M., van Amersfoort E.S., van Dam A.-M., Breve J.J.P., Kuiper J., van Berkel Th.J.C. Apolipoprotein E: An Established modulator of lipid metabolism with a new role in the modulation of sepsis. // In: Abstr. 5th Ann. Scand. Atherosclerosis Conf., 1998.
82. Rietschel E. T., Brade H., Holst O. et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and Immunological detoxification. // Curr. Topics in Microbiol. Immunol. - 1996. - Vol.216 - P.39-81.
83. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. // Nature - 1993. - Vol.362. P.801-809.
84. Saikku P., Leinonen M., Tenkanen L., Linnanmaki E., Ekman M.- R., Manninen V., Manttari M., Frick M., Huttunen J. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. // Ann. Intern. Med. - 1992. - Vol.116. - P.273-278.
85. Saikku P. Chlamydia pneumoniae in atherosclerosis. // J. Intern. Med. - 2000. - Vol.247(3). - P.391-396.
86. Schlichting E., Henriksen T., Lyberg T. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumor necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. // Scand. J. Clin. Lab. Invest. - 1994, - Vol.54 - P.465-473.
87. Schonbeck U., Flad H.-D., Rietschel E.Th., Loppnow H. S-form LPS induces leukocyte adhesion to human vascular endothelial cells as potent as IL-1: lipid A precursor Ia antogonizes induction of adhesion by LPS. // Endotoxin Res. - 1994. - Vol.1(1). - P.4-13.
88. Schwartz Y.Sh., Dushkin M.I., Safina A.F. Cytokine-induced enchancement of lipid biosynthesis in macrophages. // Atherosclerosis - 1997. - Vol.134, N1,2. - P.236.
89. Schwartz Y.Sh., Dushkin M.I., Safina A.F. Inflammatory cytokines are able to induce macrophage-derived foam cell formation via lipid biosinthesis enhancement. // Abstracts of the 5th Annual Scandinavian Atherosсlerosis Conference an International Meeting, Humlebak, Copenhagen. - 1998. -P.65.
90. Schwartz Y.Sh., Dushkin M.I., Kuznetsova I.S. Chronic endotoxinemia enhances atherogenesis // J. Endotoxin Research - 2000. Vol.6, № 2. - P.113-114.
91. Shor, A., Kuo C., Patton D.. Detection of Chlamydia pneumoniae Поступила 22/11-2000 *** in coronary arterial fatty streaks and atheromatous plaques. // S. Afr. Med. J. - 1992. - Vol.82. - P.158-161.
92. Skarnes R.C., Rosen F.S., Shear M.J., Landy M. Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. // J.Exp.Med.. - 1958. - Vol.108 - P.685-700.
93. Skarnes R.C. In vivo interaction of endotoxin with lipoprotein having esterase activity. // J.Bacteriology - 1968. - Vol.95. - P.2031-2034.
94. Takada H., Iki K., Sakuta T., Sugiyama A., Sawamura Sh., Hamada Sh. Lipopolysaccharides of oral black pigmented bacteria and periodonta diseases. // In: Progress in clinical and biological research, vol.392: Bacterial endotoxins: Lipopolysaccharides from genes to therapy (Eds. J.Levin, C.R.Alving, R.S.Munford, H.Redl), WileyLiss Inc. -1995. - P.59-68.
95. Ulevitch R.J., Johnston A. R. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. // J.Clin.Invest.. - 1979. - Vol.64. - P.1516-1524.
96. van Lenten B.J., Fogelman A.M., Haberland M.E., Edwards P.A. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharides. // Proc. Natl. Acad. Sci. - 1986. - Vol.83. - P.2704-2708.
97. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. // J. Am. Coll. Cardiol. - 1999. - Vol.34(7). - P.1975-1981
98. Wilkinson, S. G. Bacterial lipopolysaccharides - themes and variations. Prog. Lipid Res. - 1996. - Vol.35. - P.283-343.
Рецензия
Для цитирования:
Шварц Я.Ш., Душкин М.И. ЭНДОТОКСИНЕМИЯ И АТЕРОСКЛЕРОЗ. Российский кардиологический журнал. 2001;(4):83-92.
For citation:
Schwarz Y.S., Dushkin M.I. ENDOTOXINEMIA AND ATHEROSCLEROSIS. Russian Journal of Cardiology. 2001;(4):83-92. (In Russ.)
Просмотров:
459
Послать статью по эл. почте 